The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 3074-3077

  Nader, Shahla ^a   Riad Gabriel, Maggy G ^b   Saad, Mohammed F ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; GLUCOSE; INSULIN; LEPTIN; ORAL CONTRACEPTIVE AGENT; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN RESISTANCE; OBESITY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ANDROGENS; BIOLOGY; CARBOHYDRATE METABOLIC EFFECTS; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS, PROGESTIN--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS--PHARMACODYNAMICS; CONTRACEPTIVE METHODS--SIDE EFFECTS; DESOGESTREL--PHARMACODYNAMICS; DIABETES MELLITUS--PREVENTION AND CONTROL; DISEASES; ENDOCRINE SYSTEM; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; GENITALIA; GENITALIA, FEMALE; GLUCOSE METABOLISM EFFECTS; GLUCOSE TOLERANCE TEST; HORMONES; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; METABOLIC EFFECTS; ORAL CONTRACEPTIVES, COMBINED--SIDE EFFECTS; ORAL CONTRACEPTIVES--SIDE EFFECTS; OVARIAN EFFECTS; OVARY; PHYSIOLOGY; PROSPECTIVE STUDIES; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES; UROGENITAL SYSTEM;

ADULT; BODY MASS INDEX; CONTRACEPTIVES, ORAL; DESOGESTREL; ESTRADIOL; ESTRONE; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERANDROGENISM; INSULIN; LEPTIN; OSMOLAR CONCENTRATION; PROTEINS; REFERENCE VALUES;

EID: 0030959787     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.9.3074     Document Type: Article

References (37)

1. Barbieri RL, Smith S, Ryan KJ. 1988 The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 50:197-212.
2. Nader S. 1991 Polycystic ovary syndrome and the androgen-insulin connection. Am J Obstet Gynecol. 165:346-348.
3. Dunaif A. 1995 Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med. 98:33S-39S.
4. Nahum R, Thong KJ, Hillier SG. 1995 Metabolic regulation of androgen production by human thecal cells in vitro. Hum Reprod. 10:75-81.
5. Brzechffa PR, Jakimiuk AJ, Agarwal SK, Weitsman SR, Buyalos RP, Magoffin DA. 1996 Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 81:4166-4169.
6. Zhang Y, Proenca R, Miffei M, Barone M, Leopold L, Friedman JM. 1994 Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425-432.
7. Maffei M, Halaas J, Ravussin E, et al. 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1:1155-1161.
8. Considine RV, Sinha MK, Heiman ML, et al. 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 334:292-295.
9. Rosenbaum M, Nicolson M, Hirsch J, et al. 1996 Effects of gender, body composition, menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 81:3424-3427.
10. Ostlund Jr RE, Wang J W, Klein S, Gingerich R. 1996 Relation between plasma Ieptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab. 81:3909-3913.
11. Saad MF, Damani S, Gingerich RL, et al. 1997 Sexual dimorphism in plasma Ieptin concentration. J Clin Endocrinol Metab. 82:579-584.
12. Segal KR, Landt M, Klein S. 1996 Relationship between insulin sensitivity and plasma Ieptin concentration in lean and obese men. Diabetes. 45:988-991.
13. Gabriel M, Jinagouda S, Boyadjian R, Kades W, Ayad M, Saad MF. 1996 Is Ieptin the link between obesity and insulin resistance? Diabetes. 45:51A.
14. Cioffi JA, Shafer AW, Zupancic TJ, et al. 1996 Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nat Med. 2:585-589.
15. Chehab FF, Lim ME, Lu R. 1996 Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet. 12:318-320.
16. Barash IA, Cheung CC, Weigle DS, et al. 1996 Leptin is a metabolic signal to the reproductive system. Endocrinology. 137:3144-3147.
17. Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD. 1996 Gender differences in plasma leptin concentrations. Nat Med. 2:949-950.
18. Gaspard UJ, Lefebvre PJ. 1990 Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease. Am J Obstet Gynecol. 163:334-343.
19. Godsland IF, Crook D, Simpson R, et al. 1990 The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med. 323:1375-1381.
20. Moghetti P, Tosi F, Castello R, et al. 1996 The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab. 81:952-960.
21. Runnebaum B, Rabe T. 1987 New progestogens in oral contraceptives. Am J Obstet Gynecol. 157:1059-1063.
22. Dunaif A, Green G, Phelps RG, Lebwohl M, Fullerweit W, Lewy L. 1991 Acanthosis nigricans, insulin resistance, and hyperandrogenism: clinical, histological, and biochemical findings. J Clin Endocrinol Metab. 73:590-595.
23. Report of a WHO Study Group. 1985 Diabetes mellitus. WHO Tech Rep Ser. 727:9-17.
24. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith HC, Landt M. 1996 Radioimmunoassay of leptin in human plasma. Clin Chem. 42:942-946.
25. SPSS. 1993 SPSS user's guide, release 6.1. Chicago: SPSS.
26. Kuhl H, Jung-Hoffman C, Weber J, Boehm BO. 1993 The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters. Contraception. 47:55-68.
27. Laakso M. 1993 How good a marker is insulin level for insulin resistance? Am J Epidemiol. 137:959-965.
28. Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V. 1991 Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab. 74:64-70.
29. Watanabe RM, Azen CG, Roy S, Perlman JA, Bergman RN. 1994 Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors. J Clin Endocrinol Metab. 79:1277-1283.
30. Hamilton BS, Paglia D, Kwan AY, Deitel M. 1995 Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med. 1:953-956.
31. Lönnqvist F, Arner P, Nordfors L, Schalling M. 1995 Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med. 1:950-953.
32. Ogawa Y, Masuzaki H, Isse N, et al. 1995 Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest. 96:1647-1652.
33. Maffei M, Fei H, Lee G-H, et al. 1995 Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci USA. 92:6957-6960.
34. Houseknecht KL, Flier SN, Frevert EU, Frederich RC, Flier JS, Kahn BB. 1996 Leptin secretion correlates with adipocyte size in genetic and dietary obesity. Diabetes. 45:41A.
35. Haffner SM, Miettinen H, Karhapää P, Mykkänen L, Laakso M. 1997 Leptin concentrations, sex hormones and cortisol in non-diabetic men. J Clin Endocrinol Metab. 82:1807-1809.
36. Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. 1996 Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue. Diabetologia. 39:353-356.
37. Allen LS, Hines M, Shryne JE, Gorski RA. 1989 Two sexually dimorphic cell groups in the human brain. J Neurosci. 9:497-506.